Aspergillus viridinutans: an agent of adult chronic invasive aspergillosis

References

• Hope WW, Denning DW. Invasive aspergillosis: current and future challenges in diagnosis and therapy. Clin Microbiol Infect 2004; 10: 2–4.
   PubMed Web of Science ®Google Scholar
• Maschmeyer G, Haas A, Cornely OA. Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 2007; 67: 1567–1601.
   PubMed Web of Science ®Google Scholar
• Krishnan S, Manavathu EK, Chandrasekar PH. Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance. Mycoses 2009; 52: 206–222.
   PubMed Web of Science ®Google Scholar
• Person AK, Chudgar SM, Norton BL, Tong BC, Stout JE. Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis. J Med Microbiol 2010; 59: 834–838.
   PubMed Web of Science ®Google Scholar
• Sugui JA, Vinh DC, Nardone G, . Neosartorya udagawae (Aspergillus udagawae), an emerging agent of aspergillosis: how different is it from Aspergillus fumigatus? J Clin Microbiol 2010 48: 220–228.
   PubMed Web of Science ®Google Scholar
• McLennan EI, Tucker SC, Thrower LB. New soil fungi from Australian heathland: Aspergillus, Penicillium, Spegazzinia. Austral J Bot 1954; 2: 355–364.
   Google Scholar
• Varga J, Tóth B, Rigó K, Debets F, Kozakiewicz Z. Genetic variability within the Aspergillus viridinutans species. Folia Microbiol (Praha) 2000; 45: 423–428.
   PubMed Web of Science ®Google Scholar
• Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Cuenca-Estrella M, Rodriguez-Tudela JL. Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification. Antimicrob Agents Chemother 2008; 52: 1244–1251.
   PubMed Web of Science ®Google Scholar
• Katz ME, Dougall AM, Weeks K, Cheetham BF. Multiple genetically distinct groups revealed among clinical isolates identified as atypical Aspergillus fumigatus. J Clin Microbiol 2005; 43: 551–555.
   PubMed Web of Science ®Google Scholar
• Yaguchi T, Horie Y, Tanaka R, . Molecular phylogenetics of multiple genes on Aspergillus section Fumigati isolated from clinical specimens in Japan. Nip Ishinkin Gakkai Zasshi 2007; 48: 37–46.
   PubMedGoogle Scholar
• Vinh DC, Shea YR, Jones PA, . Chronic invasive aspergillosis caused by Aspergillus viridinutans. Emerg Infect Dis 2009; 15: 1292–1294.
   PubMed Web of Science ®Google Scholar
• Sigler L, Kennedy MJ. Aspergillus, Fusarium, and other opportunistic moniliaceous fungi. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH Manual of Clinical Microbiology, 7th. Washington, DC: ASM Press, 1999: 1212–1241.
   Google Scholar
• Clinical and Laboratory Standard Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; approved standard. Document M38-A2, 2nd edn, Wayne, PA: CLSI, 2008.
   Google Scholar
• Walsh TJ, Anaissie EJ, Denning DW, . Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Inf Dis 2008; 46: 327–360.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Messer SA, Boyken L, . In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species. J Clin Microbiol 2008; 46: 2568–2572.
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A, Johnson E, Hockey H, Troke P. Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole phase III clinical studies. J Antimicrob Chemother 2008; 61: 616–620.
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Gomez-Lopez A, Mellado E, . Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother 2006; 50: 917–921.
   PubMed Web of Science ®Google Scholar
• Sabatelli F, Patel R, Mann PA, . In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother 2006; 50: 2009–2015.
   PubMed Web of Science ®Google Scholar
• Lass-Florl C, Mayr A, Perkhofer S, . Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother 2008; 52: 3637–3641.
   PubMed Web of Science ®Google Scholar
• European Committee for Antimicrobial Susceptibility Testing. Method for the determination of broth dilution MICs of antifungal agents for conidia forming moulds. Definitive document E.DEF9.1, 2008. http://www.eucast.org
   Google Scholar